Background: The transition to microgravity eliminates the hydrostatic gradients in the vascular
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Introduction
An immediate effect of the transition to microgravity during early spaceflight is a loss of the hydrostatic gradient in the venous vasculature, resulting in a cephalad fluid shift. (1;2) The estimated loss of lower extremity volume is in the order of 1to 2 liters, (1;3) which is larger than the shifts seen on Earth when moving from upright to supine or even head-down-tilt posture.
While the mechanisms that mitigate the pooling of blood in the lower extremities apparently continue to act in the absence of gravity, central venous pressure (CVP) has been measured invasively during spaceflight and noted to decrease by about 5-to 7-mmHg, with no clinically significant long-term changes in cardiac output. device also has been used in space to "retrain" the cardiovascular system in the final days of long-duration missions and prevent orthostatic hypotension upon landing.
The custom-made cuffs are calibrated in a special preflight tilt- 
Hypothesis
The Braslet-M device, when used per the current calibration and procedures, will:
consistently cause fluid sequestration and reduce flow velocities in the venous vascular bed of lower extremities in microgravity, acutely reducing the circulating volume;
reduce cardiac preload in microgravity for the duration of application;
facilitate the effects of the Valsalva and Mueller maneuvers on the filling (distention) and behavior of internal jugular vein observed by real-time sonography.
Methods
Subject Selection
All ISS crewmembers were medically certified for space flight by the ISS Multilateral 
Braslet Calibration
Braslet-M sets were custom made by the manufacturer (Kentavr-Nauka, Ltd., Moscow, Russia) for each subject and then individually calibrated as a nominal operational countermeasure in a standardized preflight tilt-table procedure. Cranial rheographic data were acquired in the baseline state (supine) and then in -30° head-down position. The Braslet was gradually tightened in a step-wise fashion while trained experts recorded subjective responses and followed rheographic tracing and the appearance of the subject. The setting of the device was thus determined to assure subjective improvement (reduction of fullness of the head, nasal congestion, and often a perception of not being tilted) as well as return of rheographic tracing to the baseline type. (Figure 1 ) This setting is considered to provide appropriate compression of the extremity for operational purposes, therefore the same setting was used in this study.
Training
Approximately four months before launch, each subject received two hours of operator and/or subject familiarization, including hands-on instruction by an expert sonographer using a 
On Orbit Data Acquisition
The study spanned three consecutive ISS Expeditions with six, five and four sessions respectively involving nine crewmembers from 33 to 185 days after launch (101± 46, mean±SD). No ground data were collected before or after the mission, as each crewmember served as their own control.
During each on-orbit session, real-time video from the ISS ultrasound system was transmitted to Mission Control Center -Houston (MCC-H) using the ISS video subsystem.
Two-way private audio was provided to the expert sonographer in MCC-H. The crew-members were remotely guided through the study protocol, which typically took 60 minutes to perform.
( Figure 2 .)
The astronauts were allowed to refine specific restraining techniques for both the subject and the operator to allow unrestricted use of the keyboard, access to the thoracic region and both thigh areas of the subject, and assure mutual stability for the examination in the microgravity environment. Attention was paid to the prevention of hand fatigue of the operator. In some cases, the subject assisted with ultrasound keyboard manipulations.
The cardiac ultrasound examination was conducted using the four-chamber apical view All the ultrasound images were reviewed and analyzed by registered sonographers and a cardiologist certified by the National Board of Echocardiography(24) external to the investigator group, to verify the diagnostic quality of the data. Depending on the quality of the data, all the parameters listed in Table 1 were measured in three different frames or cardiac cycles. In some subjects, data points from a particular step of the protocol were rejected due to poor quality;
however, data of acceptable fidelity were obtained from all subjects.
Statistical Methods
Data analysis consisted of two phases. Phase I was an exploratory analysis designed to identify outcome parameters ( Table 1 ) that showed evidence of being affected by the Braslet for any or all of the test conditions. For this phase, we made no distributional assumptions and used Somers D, a non-parametric measure of association to describe consistency of change with regard to Braslet status (on or off) taking into account differences between subjects and possibly flight days within a mission for the same subject. In Table 1 , combinations of parameters and test conditions were flagged ( see "stars" Table 1 
Results
Approximately 7000 measurements were made to obtain 27 ECHO and peripheral vascular parameters acquired during the 15 ultrasound sessions on nine subjects. (See Table 1 ) Out of the 17 sessions actually scheduled, only 15 were successfully conducted which produced a useful set of data.
Some anomalies include:
One session -not performed due to ultrasound hardware failure One session -cardiac image data were not captured properly due to a procedural error One session -no ECG tracing was obtained with vascular images One session -last 50% of data lost due to hardware failure. One session -not performed due to scheduling constraints One session -respiratory maneuvers not properly synchronized causing difficulties with data analysis.
Phase 1 Analysis: Effect of Braslet alone on Respiratory Maneuvers
Insert Table 1 here
After correcting for multiple testing (Statistical Methods), the Braslet cuff was identified as producing a statistically significant effect on the mean response during at least one type of maneuver (including baseline) in 10 of the 27 parameters measured. In particular significant decreases with application of the cuff were observed in cardiac output, LV Stroke volume, left lateral E′, Mitral A and E wave velocity, and right IVRT during baseline; left lateral A′ and E′ during the modified Valsalva maneuver; and left lateral E′, right IVRT, and right TEI index during the modified Mueller maneuver. Significant increases were observed in Mitral deceleration time (baseline and Valsalva) and in FEV V area (baseline) (stars in Table 1 ).
Phase 2 Analysis: Comparison of Valsalva, Mueller and Baseline +Maneuvers with and without Braslet
Again after correction for multiple testing, we observed statistical evidence that the effect of the Braslet cuff (on vs. off) was significantly different in 7 parameters between at least two of the maneuvers (including baseline) (last column of Table 1 ). More specifically, parameters
showing evidence of this differential change were cardiac output, heart rate, IJV area, LV diastolic volume, left lateral S′, mitral deceleration time, and right lateral E′.
Braslet Release
After completing all the imaging components with maneuvers in Braslet-OFF and Braslet-ON states, the cardiac probe was positioned to get a continuous four-chamber view. The operator crewmember rapidly released the Velcro straps on both Braslet cuffs, and the following 10 cardiac cycles were recorded. Unfortunately, the four-chamber view (n=6) was difficult to maintain during the Braslet resulting in poor image quality, therefore it was replaced with the more stable Tissue Doppler (n=9).
Discussion
Realtime remote expert guidance of the non-physician crewmembers allowed the ultrasound operators to obtain high quality images and data that were critical to the success of this study. Herault et al (26) reported that despite adequate training of Mir cosmonauts before flight, the quality of the ultrasound obtained for in-flight studies prevented them from determining changes in cardiac parameters of less than 10%. In our study, the use of experts with substantial remote image acquisition experience and an established and tested system of balanced expertise distribution (pre-flight and just-in-time training, supporting tools and materials, and remote guidance) enabled data acquisition with quality acceptable for real-time assessment and thorough retrospective analysis.
Tissue Doppler (TD) was performed for the first time in space during this investigation. with thigh cuffs inflated to 50 mmHg for 15 minutes, however these subjects would have been consider hypervolemic compared to microgravity.
Herault et al (26) measured the effects of wearing the Braslet for five hours on six cosmonauts during a 6-month stay on the Mir space station and reported stroke volume and cardiac output reduction of 15% and 14% respectively after one month of space flight. It is interesting to note that these changes became minuscule after three months of space flight, and the Braslet actually increased stoke volume and cardiac output after five months of space flight.
They also report that femoral vein area increased by ~20% with the Braslet applied at one and three months, but five months into the flight this increase was only 9%. We did not observe this trend on any subject and it should be noted that the countermeasures used on the ISS are very effective at preventing muscle atrophy of the lower extremities. Muscle loss may have occurred during the Mir missions, altering the fit and, therefore, the efficacy of the Braslet. Compared to supine baseline values they found that facial skin thickness increased by 5% after seven days of HDT but, after wearing the Braslet for eight hours the skin thickness was reduced by 5%. This agrees with the subjective comments by Herault et al (26) , which document that all astronauts who wore the Braslet during their study in space claim to have had a "sensation of comfort." Matsnev et al (40) reported that when Braslet was employed on Soyuz-38 the cosmonauts reported a reduction in space adaptation syndrome symptoms (dizziness, congestion and headaches).
Kirsch et al (14) measured CVP after 22 hours of microgravity during the Spacelab 1 mission and found it to be less than the preflight supine levels in two subjects. They repeated this during the Spacelab D1 missions and found that the CVP again fell to levels below preflight supine 20 to 40 minutes after liftoff. This is consistent with the findings by Buckey et al (4), which found that invasive CVP fell to 2.5 cm H 2 O immediately at the transition to microgravity on the Space Life Sciences 1 mission. Foldager et al (15) reported that CVP decreased to 6.5 -2.0 mmHg after three hours of microgravity exposure during the Spacelab D2 (n=4) and Space Life Sciences 2 (n=2) missions.
The monitoring of the IJV using thoracic maneuvers may replace the terrestrial bedside JVP to determine volume status of the microgravity patient. We agree with the hypothesis of 
Conclusion
The Braslet device reduces the effective circulating volume by sequestering fluid in the lower extremities, as directly observed by vascular ultrasound and supported by the reduced preload indices measured by echocardiography. Vascular ultrasound confirmed reduced distention of the jugular venous system and increased sensitivity of the jugular vein area to thoracic maneuvers. All of these findings combined with subjective comments from crewmembers that the Braslet seems to reduce the sense of "fullness in the head," suggests that the relative cranial venous insufficiency caused by microgravity is partially alleviated by the Braslet. The hazards secondary to wearing the occlusive Braslet cuffs in microgravity for an extended time (greater than 1 hour) are not known, and will be investigated in future studies. A statistically significant reduction in jugular venous filling (and probably, pressure"desaturation") also observed during Braslet application, which coupled with the added influence of negative airway pressure to consistently collapse the internal jugular vein. This effect has important diagnostic and therapeutic implications for space medicine, and should be further studied from both perspectives.
Remotely guided ultrasound provides an effective and objective means of measuring the physiological effects of the Braslet and produces data quality that is superior to previous Braslet investigations in space. Valsalva and Mueller maneuvers may be additional maneuvers needed to observe the patient at the microgravity bedside to determine volume status.  = considered a significant change due to the BRASLET OFF/ON treatment Table 1 
